Ono Pharmaceutical Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, Ono Pharmaceutical stock has a consensus rating of "Hold" and an average price target of ¥2,292. The average 1-year stock price forecast is 3.53% higher than the current stock price, while the lowest is ¥1,800 (-18.68%) and the highest is ¥2,950 (+33.27%).

Price Target: ¥2,292 (+3.53%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	¥1,800	¥2,292	¥2,350	¥2,950
Change	-18.68%	+3.53%	+6.17%	+33.27%

Analyst Ratings

The average analyst rating for Ono Pharmaceutical stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	1	1	1	1	2	2
Buy	0	0	0	0	0	0
Hold	8	8	8	8	7	7
Sell	1	1	1	1	1	1
Strong Sell	2	2	2	2	2	2
Total	12	12	12	12	12	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Stephen Barker Jefferies	Jefferies	Hold Maintains ¥2,500	Hold	Maintains	¥2,500	+12.94%	May 29, 2026
Unknown Analyst Goldman Sachs No rating	Goldman Sachs	Sell Maintains ¥1,500 → ¥1,900	Sell	Maintains	¥1,500 → ¥1,900	-14.16%	Apr 15, 2026

Financial Forecast

Revenue This Year

454.85B

from 515.79B

-11.81%

from 515.79B

Revenue Next Year

443.47B

from 454.85B

-2.50%

from 454.85B

EPS This Year

n/a

from -

EPS Next Year

n/a

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	361.36B	447.19B	502.67B	486.87B	515.79B	454.85B
Revenue Growth	16.84%	23.75%	12.41%	-3.14%	5.94%	-11.81%
Gross Profit	267.85B	337.13B	375.55B	338.92B	374.07B	348.98B
Gross Margin	74.12%	75.39%	74.71%	69.61%	72.52%	76.72%
Operating Income	110.82B	150.05B	160.30B	61.79B	92.24B	95.53B
Net Income	80.52B	112.72B	127.98B	50.05B	69.77B	68.94B
Dividend / Share	56.00	70.00	80.00	80.00	80.00	78.21
Dividend Growth	-	25.00%	14.29%	-	-	-2.24%
Free Cash Flow	18.09B	116.64B	79.78B	71.82B	64.83B	116.75B
No. Analysts	-	-	-	-	-	12

Financial currency is JPY.

Revenue Forecast

Revenue	2027	2028	2029
High	479.2B
Avg	454.9B
Low	445.6B

Revenue Growth

Revenue Growth	2027	2028	2029
High	-7.1%
Avg	-11.8%
Low	-13.6%

EPS Forecast

EPS	2027	2028	2029
High	-
Avg	-
Low	-

EPS Growth

EPS Growth	2028	2029
High	-
Avg	-
Low	-